MULTIMODAL DETECTION OF TISSUE ABNORMALITIES BASED ON RAMAN AND BACKGROUND FLUORESCENCE SPECTROSCOPY

Patent №

US 8,326,404

Granted

2012-12-04

Filed 2008

Owner

BC CANCER AGENCY

+1 more

Lab

AI components

1

vision

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

10596072

Methods and apparatus for classifying tissue use features of Raman spectra and background fluorescent spectra. The spectra may be acquired in the near-infrared wavelengths. Principal component analysis and linear discriminant analysis of reference spectra may be used to obtain a classification function that accepts features of the Raman and background fluorescence spectra for test tissue and yields an indication as to the likelihood that the test tissue is abnormal. The methods and apparatus may be applied to screening for skin cancers or other diseases.

VisionA61B 5/0071A61B 5/0035A61B 5/0075A61B 5/444A61B 5/7264G01N 21/6486G01N 21/65A61B 5/0086+1 more

AI classification

Vision1.00
AI hardware0.40
Planning0.09
Evolutionary computation0.06
Machine learning0.02
Natural language0.01
Knowledge representation0.00
Speech0.00

Ownership

BC CANCER AGENCY

assignment · 180550468

BRITISH COLUMBIA CANCER AGENCY BRANCH

correct · 304170252

© 2026 NYSGPT2525 LLC